temoporfin has been researched along with Complication, Postoperative in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buyske, J; Friedberg, JS; Glatstein, E; Hahn, SM; Metz, J; Mick, R; Pass, HI; Sterman, DH; Stevenson, J; Zhu, T | 1 |
| Baas, P; Schouwink, H | 1 |
1 trial(s) available for temoporfin and Complication, Postoperative
| Article | Year |
|---|---|
A phase I study of Foscan-mediated photodynamic therapy and surgery in patients with mesothelioma.
Topics: Aged; Capillary Leak Syndrome; Cause of Death; Chemotherapy, Adjuvant; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hematoporphyrin Photoradiation; Humans; Intraoperative Period; Male; Maximum Tolerated Dose; Mesoporphyrins; Mesothelioma; Middle Aged; Neoplasm Staging; Pleura; Pleural Neoplasms; Pneumonectomy; Postoperative Complications | 2003 |
1 other study(ies) available for temoporfin and Complication, Postoperative
| Article | Year |
|---|---|
Foscan-mediated photodynamic therapy and operation for malignant pleural mesothelioma.
Topics: Capillary Leak Syndrome; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Drug Administration Schedule; Humans; Mesoporphyrins; Mesothelioma; Photochemotherapy; Photosensitizing Agents; Pleural Neoplasms; Pneumonectomy; Postoperative Complications; Survival Analysis | 2004 |